Bitoca, Mary Margaret B.

HRN: 25-58-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/30/2024
08/05/2024
IV
4.6ml
TID
T/c Amoebiasis
Waiting Final Action 
07/31/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/31/2024
08/06/2024
PO
1mL
BID
Mouth Sores
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: